Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bourquin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Communication in oncology: now we train - but how well?F Stiefel, C Bourquin
Sozial- Und Praventivmedizin|December 2, 1998
[Prevention of hepatitis B (excluding vaccination)]H Zimmermann, C Bourquin
Semaine Des Hopitaux. Therapeutique|February 1, 1976
[Treatment of obesity. Current data on TRIAC]J Arnal, C Bourquin
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 19, 1974
[Ocular toxicity of Myambutol (author's transl)]C Bourquin, S Korol
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1976
[Ocular toxicity of myambutol]C Bourquin, S Korol
Sozial- Und Praventivmedizin|December 2, 1998
[Information strategy for physicians and public health regarding introduction of general hepatitis B vaccination in Switzerland]C Bourquin, H Zimmermann
Revue Medicale De La Suisse Romande|June 12, 1998
[Vaccination promotion in the school system]F Méan, C Bourquin, R Kammerlander
Vaccine|April 22, 2010
Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001Z Schumacher, C Bourquin, U Heininger
Revue Medicale Suisse|April 22, 2015
[Multifaceted body. 3. The contextualised body]C Bourquin, H Wykretowicz, M Saraga, et al.
Il Farmaco; Edizione Scientifica|May 1, 1970
[Pharmacological properties of reserpine 3,5,3'-triiodothyroacetate]A Magnin, B Nicod, C Bourquin, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2016
Communication in oncology: now we train - but how well?F Stiefel, C Bourquin
Sozial- Und Praventivmedizin|December 2, 1998
[Prevention of hepatitis B (excluding vaccination)]H Zimmermann, C Bourquin
Semaine Des Hopitaux. Therapeutique|February 1, 1976
[Treatment of obesity. Current data on TRIAC]J Arnal, C Bourquin
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 19, 1974
[Ocular toxicity of Myambutol (author's transl)]C Bourquin, S Korol
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1976
[Ocular toxicity of myambutol]C Bourquin, S Korol
Sozial- Und Praventivmedizin|December 2, 1998
[Information strategy for physicians and public health regarding introduction of general hepatitis B vaccination in Switzerland]C Bourquin, H Zimmermann
Revue Medicale De La Suisse Romande|June 12, 1998
[Vaccination promotion in the school system]F Méan, C Bourquin, R Kammerlander
Vaccine|April 22, 2010
Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001Z Schumacher, C Bourquin, U Heininger
Revue Medicale Suisse|April 22, 2015
[Multifaceted body. 3. The contextualised body]C Bourquin, H Wykretowicz, M Saraga, et al.
Il Farmaco; Edizione Scientifica|May 1, 1970
[Pharmacological properties of reserpine 3,5,3'-triiodothyroacetate]A Magnin, B Nicod, C Bourquin, et al.
Pageof 4